140 related articles for article (PubMed ID: 7865314)
1. The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection.
MacQueen KM; Buchbinder S; Douglas JM; Judson FN; McKirnan DJ; Bartholow B
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S261-4. PubMed ID: 7865314
[No Abstract] [Full Text] [Related]
2. Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials.
Douglas JM; Judson FN; Parks JP; Buchbinder S; McKirnan D
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S257-60. PubMed ID: 7865313
[No Abstract] [Full Text] [Related]
3. Preparations for AIDS vaccine trials. Developing brief valid screening instruments for HIV-related sexual risk behavior among gay and bisexual men.
McKirnan DJ; Doetsch J; Vanable P; Buchbinder S; Douglas JM; Judson F
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S285-8. PubMed ID: 7865320
[TBL] [Abstract][Full Text] [Related]
4. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.
Temoshok LR
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S277-80. PubMed ID: 7865318
[No Abstract] [Full Text] [Related]
5. Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials.
MacQueen KM; Buchbinder SP; Douglas JM; Judson FN; McKirnan DJ; Bartholow BN
AIDS Public Policy J; 1996; 11(2):104-12. PubMed ID: 10915243
[No Abstract] [Full Text] [Related]
6. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
[TBL] [Abstract][Full Text] [Related]
7. Interest in HIV vaccines among injection drug users in Baltimore, Maryland.
Vlahov D; Astemborski J; Solomon L; Galai N; Basarab L; Nelson KE
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S265-8. PubMed ID: 7865315
[TBL] [Abstract][Full Text] [Related]
8. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
[TBL] [Abstract][Full Text] [Related]
9. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
10. Preparations for AIDS vaccine trials. Recruitment and retention of in- and out-of-treatment injection drug users.
Woody GE; Metzger D; Mulvaney F
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S197-9. PubMed ID: 7865300
[No Abstract] [Full Text] [Related]
11. Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.
Chesney MA; Lurie P; Coates TJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):30-5. PubMed ID: 7712232
[No Abstract] [Full Text] [Related]
12. Behavioral studies relevant to vaccine trial preparation: an introduction.
Turner CF; Sheon AR
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S273-6. PubMed ID: 7865317
[TBL] [Abstract][Full Text] [Related]
13. Community heroes or "high-risk" pariahs? Reasons for declining to enroll in an HIV vaccine trial.
Newman PA; Daley A; Halpenny R; Loutfy M
Vaccine; 2008 Feb; 26(8):1091-7. PubMed ID: 18237829
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and cohort development for HIV vaccine trials in Haiti.
Deschamps MM; Johnson WD; Pape JW
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S231-3. PubMed ID: 7865308
[TBL] [Abstract][Full Text] [Related]
15. Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.
Lampinen TM; Chan K; Remis RS; Merid MF; Rusch M; Vincelette J; Logue K; Popovic V; Alary M; Schechter MT; Hogg RS
CMAJ; 2005 Feb; 172(4):479-83. PubMed ID: 15710939
[TBL] [Abstract][Full Text] [Related]
16. Scaling HIV vaccine attitudes among gay men in Sydney, Australia.
Van De Ven P; Bartholow B; Rawstorne P; Crawford J; Kippax S; Grulich A; Prestage G; Woodhouse M; Murphy D
AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1333-7. PubMed ID: 12487804
[TBL] [Abstract][Full Text] [Related]
17. A small dose of HIV? HIV vaccine mental models and risk communication.
Newman PA; Seiden DS; Roberts KJ; Kakinami L; Duan N
Health Educ Behav; 2009 Apr; 36(2):321-33. PubMed ID: 18032589
[TBL] [Abstract][Full Text] [Related]
18. Vaccines.
AIDS Policy Law; 1999 Aug; 14(14):12. PubMed ID: 11367001
[TBL] [Abstract][Full Text] [Related]
19. Large HIV vaccine trial begins.
Santiago L
GMHC Treat Issues; 1998 Oct; 12(10):1-5. PubMed ID: 11365900
[TBL] [Abstract][Full Text] [Related]
20. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
Priddy FH; Cheng AC; Salazar LF; Frew PM
Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
